全国21/13/18三体产前筛查引入后22q11.2缺失与重复产前检出增加
丹麦基于全国细胞遗传学登记库的横断面人群研究,比较1998-2004年与2005-2017年22q11.2缺失/重复及21、13、18三体的诊断时机,共纳入4562例。2004年引入包含早孕期联合筛查(cFTS)的全国三体产前筛查后,22q11.2缺失产前检出比例由4.3%升至27.3%,22q11.2重复由0/6升至26/87,三体产前检出比例亦上升。
要点
- 引入非针对22q11.2的全国三体产前筛查后,22q11.2缺失产前检出由4.3%升至27.3%。
- 22q11.2重复产前病例由0/6增至26/87。
- 更多病例在孕期更早被识别,但出生后诊断时机未见普遍提前。
核心结论
- 引入并非以检出22q11.2缺失/重复为目标的全国三体产前筛查后,22q11.2缺失与22q11.2重复的产前检出比例上升。
- 筛查引入后更多病例在孕期更早被检出,但出生后诊断时机未普遍提前。
研究设计与样本
- 丹麦全国细胞遗传学中央登记库的横断面、人群登记研究,共纳入4562例。
- 比较1998-2004年与2005-2017年诊断的病例,按14+0周、22+0周及出生前(产前)或1岁/10岁前(出生后)划分诊断时机。
主要发现
- 22q11.2缺失产前检出比例由4.3%(95%CI:0.9-12.0%)升至27.3%(21.2-34.0%)。
- 22q11.2重复产前病例/全部病例由0/6升至26/87。
- 21、13、18三体出生前检出比例同样上升。
临床怎么用
- 提示面向三体的常规产前筛查可间接提高22q11.2缺失/重复的产前检出,咨询时应关注这一非预期获益。
- 对产前筛查提示异常者,应知晓22q11.2缺失/重复可能被一并识别,需做好结果解读与遗传咨询。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate time of diagnosis of 22q11.2 deletion and 22q11.2 duplication as well as trisomies 21, 13, and 18 before and after introduction of a prenatal screening program including combined first-trimester screening (cFTS) for the trisomies in Denmark in 2004. METHOD: Cross-sectional, population-based register study employing The Danish Cytogenetic Central Register. Proportions of cases diagnosed 1998-2004 and 2005-2017 were compared before 14+0 and 22+0 weeks and birth (prenatal cases) or up to 1 or 10 years of age (postnatal cases). RESULTS: In total, 4562 cases were included. From 1998-2004 to 2005-2017, the proportion of 22q11.2 deletion cases identified prenatally increased from 4.3% (95% CI: 0.9-12.0%) to 27.3% (21.2-34.0%), while for 22q11.2 duplication an increase from 0/6 to 26/87 (prenatal cases/all cases) was observed. Similarly, proportions of trisomies 21, 13, and 18 detected before birth increased. A greater proportion of the studied conditions was identified earlier in pregnancy, but not generally earlier in the postnatal course. CONCLUSION: Proportions of 22q11.2 deletion and 22q11.2 duplication identified prenatally increased after introduction of a prenatal screening program not aimed specifically to identify these conditions,. A greater proportion of all cases were detected earlier in pregnancy, but not earlier postnatally, following introduction of screening.
引用
- Steffensen EH, Hyett J, Petersen OB, et al. Increased prenatal detection of 22q11.2 deletion and 22q11.2 duplication after introduction of nationwide prenatal screening for trisomy 21, trisomy 13, and trisomy 18. Prenat Diagn. 2020. PMID: 33080663. doi:10.1002/pd.5851
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。